EGFR and hepatocellular carcinoma: Western blotting analysis also demonstrated that NGI-1 substantially reduced the phosphorylation levels of EGFR, AKT (Ser473 and Thr308) and ERK5 in HCC cells, regardless of whether these cells were treated with EGF (Fig. 6j).